What Happens When Pot Becomes Legal?
$5.5 million study to probe the impact of marijuana legalization on use, behavior, mental health.
EVIO Expands Testing Services at its Northern California Laboratory
In anticipation of California's new testing rules EVIO has invested in additional instrumentation to offer a full suite of testing services including pesticide, microbiological, and expanded cannabinoid potency testing.
Canada to Invest Further $36.4M in Cannabis Education, Awareness and Surveillance
The funding will be used to inform Canadians of the health and safety risks of cannabis use and drug-impaired driving.
Front Range Bio, UC Davis Form Partnership for Cannabis Genomics Research
The project aims to improve this crop to reduce growers reliance on pesticides and excessive application of fertilizers.
Canada House Announces Agreement to Focus on Canadian Extraction Market
The Joint Venture will initially focus on building out an approximate 2,000 square foot facility at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR.
Could Cannabinoid-based Drugs Provide a Solution to the Global Antibiotic Crisis?
Preliminary studies indicate that cannabinoids can increase the potency and decrease the minimal required therapeutic dosages of antibacterial agents
Shimadzu, Cure Pharmaceutical and CK Sciences Form a Strategic Alliance for R&D of Pharmaceutical Cannabis Products
This collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guidelines.
Could Cannabis Be Used to Treat Asthma?
Professor Raphael Mechoulam, a cannabis research pioneer, has just received funding to identify a possible inhibitory effect of a derivative of cannabidiol on allergic airway inflammation.
Physicians Feel Unprepared to Counsel Patients On Medical Cannabis
38% of resident physicians think medical marijuana is a prescribed substance, while 78% do not know what category medical cannabis falls within the Controlled Substance Act.
